FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns a new multifunctional combined interferon drug preparation of broad spectrum of action. A preparation in the form of a suppository contains a synergistic combination of the immunomodulator interferon alpha-2b and the herbal biostimulant aloe extract; it contains vitamin E, glycine, buffer salts, tysol, lecithin and solid fat as a base in the specified proportions.
EFFECT: invention provides preparing the combined drug preparation in the form of long storage-stable suppository having the standard physical-chemical, structural and mechanical, multifunctional biological properties, higher bioavailability and synergistic therapeutic efficacy of interferon alpha-2b with the herbal biostimulant aloe extract.
1 cl, 5 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPLEX ACTION MEDICATION AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2519553C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| COMPLEX IMMUNOMODULATORY MEDICATION FOR PREVENTION OF MALFUNCTIONS AND REGULATION OF IMMUNE SYSTEM FUNCTIONING (VERSIONS) | 2011 |
|
RU2475262C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| INTRANASAL ANTIVIRAL AGENT | 2023 |
|
RU2833350C1 |
| TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
